According to Nectar Lifesciences 's latest financial reports the company's current earnings are C$0.19 Billion. In 2024 the company made an earning of C$19.78 Million, an increase over its 2023 earnings that were of C$15.74 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | -C$14.99 Million | -175.72% |
2024 | C$19.78 M | 25.63% |
2023 | C$15.74 M | 105.92% |
2022 | C$7.64 M | 1.87% |
2021 | C$7.5 M | -4.92% |
2020 | C$7.89 M | -67.92% |
2019 | C$24.61 M |